Discounted Cash Flow Rating

Return on Equity Rating

Debt to Equity Rating

Price to Earnings Rating

Analyst Rating

Simple Moving Average

Strong Buy

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Buy

Insider Trading

Neutral

Wall Street Data Solutions Rating

Sell

C

iShares MSCI Denmark ETF (EDEN)

No description provided.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/26/2012

Market Cap

284,395,729

Shares Outstanding

2,100,000

Weighted SO

N/A

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

EFNL --.--%

EIRL --.--%

ENOR --.--%

ENZL --.--%

EWN --.--%

Beta

1.0900

Last Div

1.5676

Range

95.03-130.38

Chg

0.2350

Avg Vol

9567

Mkt Cap

284395729

Exch

ETF

Country

US

Phone

NA

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0122

P/S

N/A

EV Multiple

N/A

P/FV

N/A

Div Yield %

1.2165

P/E

N/A

PEG

N/A

Payout

N/A

Current Ratio

N/A

Quick Ratio

N/A

Cash Ratio

N/A

DSO

N/A

DIO

N/A

Op Cycle

N/A

DPO

N/A

CCC

N/A

Gross Margin

N/A

Op Margin

N/A

Pretax Margin

N/A

Net Margin

N/A

Eff Tax Rate

N/A

ROA

N/A

ROE

N/A

ROCE

N/A

NI/EBT

N/A

EBT/EBIT

N/A

EBIT/Rev

N/A

Debt Ratio

N/A

D/E

N/A

LT Debt/Cap

N/A

Total Debt/Cap

N/A

Int Coverage

N/A

CF/Debt

N/A

Equity Multi

N/A

Rec Turnover

N/A

Pay Turnover

N/A

Inv Turnover

N/A

FA Turnover

N/A

Asset Turnover

N/A

OCF/Share

N/A

FCF/Share

N/A

Cash/Share

N/A

OCF/Sales

N/A

FCF/OCF

N/A

CF Coverage

N/A

ST Coverage

N/A

CapEx Coverage

N/A

Div&CapEx Cov

N/A

P/BV

N/A

P/B

N/A

P/S

N/A

P/E

N/A

P/FCF

N/A

P/OCF

N/A

P/CF

N/A

PEG

N/A

P/S

N/A

EV Multiple

N/A

P/FV

N/A

DPS

1.5676

Latest Headlines (EST)

Seeking Alpha Nov 25, 01:43 Novo Nordisk: Healthy Gains Ahead, EPS Growth Seen, Technical Strength Seeking Alpha Nov 25, 01:43 Novo Nordisk: Healthy Gains Ahead, EPS Growth Seen, Technical Strength Seeking Alpha Nov 25, 01:43 Novo Nordisk: Healthy Gains Ahead, EPS Growth Seen, Technical Strength Seeking Alpha Nov 25, 01:43 Novo Nordisk: Healthy Gains Ahead, EPS Growth Seen, Technical Strength

Revenue Product Segmentation